Overview

A Study of Ketamine Infusions to Treat Clinically-depressed ICU Patients

Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this research is to study the effects of intravenous ketamine infusions for the treatment of patients with depressive symptoms in intensive care unit (ICU).
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Ketamine